The logical assumption is the good P3 TLD greatly ups the odds of GTCB getting a partnership(s). All Biotechs can be divided into two groups....Those with a sustainable revenue stream and those without. If GTCB manages that, then in the immortal words from the movie Wall Street,, This baby's going to Pluto